LONG INDUCTION OF DRUG TOLERANCE TO ETHAMBUTOL IN TREATMENT OF MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE

被引：0
|
作者：
Mahajan, A.
Labib, E.
Shubeilat, J.
Gonzalez-Estrada, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M028
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [41] Drug-Drug Interactions of Clinical Significance in the Treatment of Patients with Mycobacterium avium Complex Disease
    Jeffrey J. Kuper
    Michelle D’Aprile
    Clinical Pharmacokinetics, 2000, 39 : 203 - 214
  • [42] Treatment Duration and Disease Recurrence After the Successful Treatment of Patients with Mycobacterium Avium Complex Lung Disease
    Furuuchi, K.
    Morimoto, K.
    Kurashima, A.
    Fujiwara, K.
    Nakamoto, K.
    Tanaka, Y.
    Tachibana, H.
    Yoshimori, K.
    Sasaki, Y.
    Ohta, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin?
    Shafran, SD
    Talbot, JA
    Chomyc, S
    Davison, E
    Singer, J
    Phillips, P
    Salit, I
    Walmsley, SL
    Fong, IW
    Gill, MJ
    Rachlis, AR
    Lalonde, RG
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) : 1401 - 1405
  • [44] Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease
    Bermudez, LE
    Kolonoski, P
    Petrofsky, M
    Wu, M
    Inderlied, CB
    Young, LS
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (12): : 1977 - 1980
  • [45] SURVEY ON USE AND PERCEPTION OF AMIKACIN FOR TREATMENT OF MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE IN THE UK
    Obradovic, M.
    Van der Laan, R.
    Hale, J.
    Gerden, E.
    Musson, L.
    THORAX, 2021, 76 : A177 - A178
  • [46] Predictive risk factors of treatment-refractory Mycobacterium avium complex lung disease
    Saito, Takahiko
    Aono, Yuya
    Kono, Masato
    Sugiura, Takuma
    Higasa, Misato
    Katsumata, Mineo
    Miwa, Hideki
    Miki, Yoshihiro
    Hashimoto, Dai
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [47] Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
    Huh, Jin-Young
    Kwon, Byoung Soo
    Park, Yea Eun
    Shim, Tae Sun
    Jo, Kyung-Wook
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] Sitafloxacin-Containing Regimen for the Treatment of Refractory Mycobacterium avium Complex Lung Disease
    Asakura, Takanori
    Suzuki, Shoji
    Fukano, Hanako
    Okamori, Satoshi
    Kusumoto, Tatsuya
    Uwamino, Yoshifumi
    Ogawa, Takunori
    So, Matsuo
    Uno, Shunsuke
    Namkoong, Ho
    Yoshida, Mitsunori
    Kamata, Hirofumi
    Ishii, Makoto
    Nishimura, Tomoyasu
    Hoshino, Yoshihiko
    Hasegawa, Naoki
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [49] Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease
    Jeong, Byeong-Ho
    Jeon, Kyeongman
    Park, Hye Yun
    Moon, Seong Mi
    Kim, Su-Young
    Lee, Soo-Youn
    Shin, Sung Jae
    Daley, Charles L.
    Koh, Won-Jung
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6076 - 6083
  • [50] Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
    Hong, Goohyeon
    Kim, Su-Young
    Jeong, Byeong-Ho
    Park, Hye Yun
    Jeon, Kyeongman
    Kwon, O. Jung
    Lee, Seung-Heon
    Kim, Chang Ki
    Shin, Sung Jae
    Koh, Won-Jung
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345